Inventis acquires 100% of Synapsys and enters the balance diagnostic equipment segment.
A unique opportunity for cross-business synergies in the audiology equipment market: Inventis is enlarging its product portfolio by entering the balance diagnostic segment and strengthening its position as the third group worldwide, and Synapsys is reinforcing its competitive position in the French market.
MARSEILLES, January 6th, 2020 – Inventis Srl (www.inventis.it) today announced that it has acquired 100% share capital of Synapsys SAS (www.synapsys.fr), the French leader in balance diagnostic systems.
With this first acquisition, Inventis, an Italian company founded in 2005 with headquarters in Padua, which designs and manufactures advanced audiological diagnostics equipment, is launching its announced strategy that aims to complete its product range, at the same time extending its international presence.
Founded in 1993 by Joël De Rosa, Synapsys is a privately-owned company and a pioneer in the vestibular field enjoying a high-profile special leading position in France. Since its foundation, Synapsys has been the major innovator in the balance diagnostic field. In 1993, thanks to the intuition of Dr. Erik Ulmer, Synapsys put the first VNG system on the market, followed by the first VHIT unit in 2006.
“By merging the R&D and commercial forces of the two companies,” states Inventis CEO Massimo Martinelli, “we aim to boost sales of the new line of vestibular systems worldwide and reinforce the market position of Synapsys in France by introducing a larger product portfolio offer. This cross-business synergy means we expect to double Synapsys sales by 2022”.
With its full range of audiometers, middle-ear analyzers, and fitting systems, marketed in more than 65 countries around the world, Inventis is a growing innovative challenger in its field. The company has always been extremely focused on exports, which now accounts for over 55% of sales, and in 2018 opened a subsidiary in the USA to reinforce its presence in its most important market after the domestic one.
In September 2018, Innovative-RFK SpA, an industrial holding, invested in a minority share of Inventis to boost the internationalization strategy by generating a steady increase in revenues and margins via acquisitions in the markets with greatest potentials.
The agreement saw Inventis launch this new strategic plan from Synapsys and France, in a vision fully aligned with that of the French company’s former owners, Stéphane Curcio and Alice De Rosa, who were appointed as the management team.
Massimo Martinelli, CEO of Inventis Srl (firstname.lastname@example.org)
Stéphane Curcio, General Manager of Synapsys SAS (email@example.com)